In a major international partnership, OIC International (USA), Medi Mold (India), and AddUp, a subsidiary of France’s Fives Group, have announced the establishment of India’s most advanced orthopedic implant manufacturing facility. The new plant, focused on 3D-printed implants and precision engineering, will be located at the Andhra Pradesh MedTech Zone (AMTZ), India’s flagship hub for medical device manufacturing.
This three-nation alliance aims to make India a key player in high-performance orthopedic implant production. The initiative aligns closely with India’s “Make in India” and healthcare self-reliance policies. OIC will launch a groundbreaking line of implants designed and produced in India using advanced additive manufacturing. These implants, built with proprietary designs, are expected to cut recovery times, reduce costs, and be scalable for both domestic use and international export.
“Our goal is to make world-class orthopedic implants both affordable and accessible in India,” said Shri Shetty, CEO of OIC International. “Local manufacturing at AMTZ lets us meet growing surgical needs while supporting the government’s vision of medical innovation and self-sufficiency.”
At the heart of this project is AddUp’s advanced metal 3D printing technology, which enables production of complex, patient-specific implants with minimal material waste. This approach offers a major shift in how orthopedic devices are designed, tested, and brought to market.
The facility will feature AddUp’s FormUp series metal printer, marking its first installation in India. Operated by Medi Mold, this setup will allow for rapid prototyping and faster delivery to hospitals, meeting rising demands in India and abroad.
“Orthopedic implant manufacturing has long relied on machining. Now, with 3D printing, we can bring smarter, faster solutions to patients,” said Dr Jitendra Sharma, Managing Director and CEO of AMTZ. “AMTZ offers the scientific infrastructure, sterilization services, and quality controls needed for this kind of advanced manufacturing.”
The partnership focuses on addressing three core challenges in orthopedic care: innovation, affordability, and accessibility. The new facility will produce cost-effective implants for India’s public healthcare system, while OIC will also serve the fast-expanding private sector.
“This collaboration allows us to bring our expertise in industrial metal 3D printing to India,” said Julian Marcilly, President of AddUp. “Together, we are enabling the production of next-generation orthopedic implants that meet international standards.”
“This partnership reflects a shared commitment to transforming India’s orthopedic market through innovation and affordability,” said Sraboni Haralalka, Executive Director of Wodehouse Capital Advisors. “We are seeing strong interest from investors—both financial and strategic—who recognize the potential of India’s medical device sector.”
Wodehouse Capital is advising OIC International on its entry into the Indian market, highlighting the venture as a model of cross-border cooperation in healthcare technology. The initiative, backed by AMTZ’s leadership, is expected to receive final approvals in the coming weeks.
The Andhra Pradesh MedTech Zone (AMTZ) is India’s premier medical technology manufacturing park, based in Visakhapatnam. Since its inception, AMTZ has been at the forefront of advancing healthcare innovation, production, and policy to support both national and global health systems.
